Do Work Accidents Play Any Role in the Increased Risk of Death Observed in 25- to 44-Year-Old Patients After Syncope?  by Barbic, Franca et al.
br
h
c
i
v
p
P
t
d
g
o
w
L
s
s
o
S
p
d
s
f
t
e
w
n
c
a
t
a
h
a
w
m
v
o
i
s
r
s
d
g
L
t
w
p
g
w
p
e
(
s
b
r
2488 Correspondence JACC Vol. 61, No. 24, 2013
June 18, 2013:2487–93between the 2 tests: 122  15 beats/min versus 121  16
eats/min.
Patients with SPEPP latent obstruction more frequently
eported PP symptoms: 92% versus 29% (p  0.007). At rest, they
ad longer posterior mitral leaflets: 1.7  0.3 cm versus 1.2  0.3
m (p  0.002). Initial post-exercise gradients were mildly higher
n patients who ultimately were SPEPP: median 34 mm Hg
ersus 16 mm Hg (p  0.008). Overall, in 9 of 13 SPEPP
atients, there was a change in therapy to relieve obstruction.
atients with SPEPP latent obstruction were more frequently
reated with beta-blockade: 100% versus 43%; 5 patients received
isopyramide and 3 underwent septal myectomy. In patients with
radient-lowering therapy because of SPEPP, Minnesota quality
f life decreased from 29  19 to 12  19 (p  0.02), but there
as no change in SPEPP patients.
We selected patients with HCM whom we suspected had
VOT obstruction as the cause of their symptoms, despite no
ignificant obstruction with standard provocations and after
ymptom-limited conventional stress exercise. In these patients, 13
f 20 (65%) were found to have substantial LVOT gradients after
PEPP, which led to an alteration in treatment for 9 of 13
atients.
Treatment choices for relief of limiting symptoms in HCM
epend heavily on the presence of LVOT obstruction. Patients’
evere symptoms and outflow obstruction may be treated success-
ully by addition of medications or septal reduction. In contrast,
here are limited options for patients who are nonobstructed. Exercise
chocardiography is an excellent modality for provocation in patients
ho might otherwise be categorized as nonobstructed (2).
However, even after a stress exercise echocardiogram that does
ot provoke gradient, the clinician may still suspect obstruction in
ertain patients. It is our current clinical practice to employ SPEPP
fter conventional stress echocardiography for patients with puta-
ive nonobstructive HCM who have: 1) New York Heart Associ-
tion 3 symptoms, especially PP worsening, who otherwise would
ave limited treatment options; 2) long leaflets or mild systolic
nterior motion but no demonstrable gradients; and 3) syncope but
here arrhythmias cannot be detected, even after prolonged
onitoring.
Valsalva and standing increase gradient due to a reduction in
enous return, a decrease in LV volume, and an increase in the
verlap between LV inflow and outflow (2). Consequent decrease
n stroke volume increases sympathetic activity, augmenting ob-
truction. In healthy individuals after a meal, peripheral vascular
esistance decreases because of mesenteric vasodilation, with a
econdary increase in stroke volume. In HCM, deleterious hemo-
ynamic effects of a meal include limited rise of stroke volume,
reater elevation in right heart pressures, and provocation of
VOT gradients (1). During exercise alone, augmented contrac-
ility increases obstruction. We have shown that selected patients
ho have no obstruction after conventional stress echocardiogra-
hy performed fasting and imaged supine may develop large
radients (median 83 mm Hg) when exercised after eating and
hen the gradient is acquired upright. We posit that SPEPP more
rofoundly alters load and contractility than conventional stress
chocardiography.
The diagnosis of latent obstruction altered therapy in 9 of 13
69%) of our patients. Five received disopyramide and 3 had
urgical septal myectomy. Patients who received new therapy
ecause of SPEPP latent obstruction experienced a dramatic
eduction in symptoms. A limitation of the study is that LVOTgradients after stress were not interpreted blindly. Because study
patients were selected by clinical suspicion, detection rates may not
be generalizable.
Not infrequently, findings in a symptomatic patient with HCM
will raise the clinical suspicion that the patient is suffering from
LVOT obstruction, even if routine stress echocardiography is
negative. Performing stress echocardiography in the PP state with
gradient acquired in the upright posture (SPEPP) correctly diag-
noses latent obstruction and thus focuses management on gradient
reduction.
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Letters to the Editor
Do Work Accidents Play Any
Role in the Increased Risk of
Death Observed in 25- to 44-
Year-Old Patients After Syncope?
We read with great interest the paper by Ruwald et al. (1) dealing
with the prognosis of healthy individuals discharged from the
emergency department or hospital after a syncope episode.
Surprisingly, fainters 25 to 44 years of age had a risk of death
higher than that of subjects older than 75 years of age, differing
from what was previously reported (2). Moreover, in individuals 25
to 44 years of age with syncope, the long-term all-cause mortality
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June 18, 2013:2487–93rate was twice that observed in the syncope group older than 75
years. This is unexpected too because the long-term (1 year)
prognosis of syncope was found to be related to aging and
comorbidities (3) that are likely to be more frequent in elderly
individuals.
The authors hypothesized that there could have been an
underdiagnosis of unrecognized cardiovascular diseases in syncope
patients 25 to 44 years of age (1).
Here we propose an additional potential explanation. A
preliminary analysis of our STePS (Short-Term Prognosis of
Syncope) (3) database indicated that 1-year syncope recurrence
in working-age (18 to 65 years) patients was as high as 14%.
Significant hazard ratio values of recurrent syncope were also
reported by Ruwald et al. (1) in the 2 groups of syncope subjects
25 to 44 years of age and 45 to 74 years of age. In a setting of
hazardous occupations, syncope recurrence might lead to fatal
work accidents in the group of syncope patients 25 to 44 years
in the present study who, potentially, are active workers.
According to the EUROSTAT Health and Safety at Work in
Europe report (4), most of work fatal accidents are classified as
occurring after “loss of control,” “slipping,” “stumbling,” and
“falling.” All these conditions might be the consequence of an
occult syncope, producing a sudden loss of consciousness and
postural tone.
We wonder whether work accidents, produced by a hidden
syncope recurrence, might play any role in the increased risk of
death found by Ruwald et al. (1) in patients 25 to 44 years of age.
potential answer might be found by matching the present study
ata with occupational accidents recordings. Should this hypoth-
sis be confirmed, an unexplored scenario characterized by remark-
ble social implications could be opened.
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cessed April 2013.Does the Absence of
Comorbidities Really Identify
Low-Risk Syncope Patients?
We read with great interest the paper by Ruwald et al. (1) on the
prognosis among healthy individuals discharged with syncope as
the primary diagnosis. However, we wonder whether the subjects
enrolled in the study can be effectively considered low-risk pa-
tients. Syncope is, most of the time, the first manifestation of
several diseases, some of which are life-threatening, such as
pulmonary embolism (2). In our opinion, the absence of comor-
bidities cannot by itself identify low-risk patients. Indeed, none of
the risk stratification tools for syncope in the emergency depart-
ment (ED), derived in both the short or long term, consider
comorbidities as risk factors, except for cardiac diseases (3). On
the contrary, patient admission to the hospital might be due to the
clinical perception that the patient is not at low risk of adverse
outcomes. During hospital admission, a specific cause of the
syncopal episode is identified in only 30% to 50% of the cases (4,5).
Thus, syncope as primary discharge diagnosis is not necessarily
consistent with the benignity of the clinical presentation.
Moreover, Ruwald et al. (1) observed an increased mortality rate
from syncope after some years, whereas in the first year, data were
inconclusive. If syncope itself were responsible for the increased
mortality, should we not observe such increase in the short term
rather than in the long term when comorbidities (3) seem to play
a more relevant role?
Finally, from our point of view, low-risk patients should be those
without comorbidities but who were also discharged from the ED. It
would be of great interest to re-analyze the data from this point of
view. We think that this analysis could strengthen the study results.
There might be a misprint in Table 3 because the 95%
confidence interval of the point estimate does not include the point
estimate itself.
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